GLAND PHARMA
Back to Cashflow Statement
|
GLAND PHARMA Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Cash Flow from Investing Activities | ₹1,705 Cr | ₹-1,757 Cr | ₹1,208 Cr | ₹-1,003 Cr | ₹-1,524 Cr |
What is the latest Cash Flow from Investing Activities ratio of GLAND PHARMA ?
Year | Cash Flow from Investing Activities |
---|---|
Mar2025 | ₹1,705 Cr |
Mar2024 | ₹-1,757 Cr |
Mar2023 | ₹1,208 Cr |
Mar2022 | ₹-1,003 Cr |
Mar2021 | ₹-1,524 Cr |
How is Cash Flow from Investing Activities of GLAND PHARMA Trending?
Years | Cash Flow from Investing Activities | % Change | |
---|---|---|---|
Mar2025 | ₹1,705 Cr | Positive | |
Mar2024 | ₹-1,757 Cr | Negative | |
Mar2023 | ₹1,208 Cr | Positive | |
Mar2022 | ₹-1,003 Cr | Negative | |
Mar2021 | ₹-1,524 Cr | - |
Compare Cash Flow from Investing Activities of peers of GLAND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLAND PHARMA | ₹31,855.8 Cr | -2.4% | 4.9% | -3.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹380,702.0 Cr | -3.3% | -4.6% | -7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,908.0 Cr | -9% | -13.6% | 24% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,896.0 Cr | -1.1% | 7% | 8.2% | Stock Analytics | |
CIPLA | ₹119,988.0 Cr | -2% | 0.6% | -4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,122.0 Cr | -1.1% | -3.8% | -13.3% | Stock Analytics |
GLAND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLAND PHARMA | -2.4% |
4.9% |
-3.5% |
SENSEX | -0.9% |
-4.4% |
1.6% |
You may also like the below Video Courses